Soaring Prevalence Of Asthmatic Disorders Propels Growth In The Asthma Drug Market Driver: A Major Catalyst in the Evolution of the Asthma Drugs Market in 2025

What combination of drivers is leading to accelerated growth in the asthma drugs market?
The increasing emergence of asthmatic conditions is likely to drive the expansion of the asthma drug market in the future. Asthma is a chronic illness characterised by the swelling and inflammation of the air passages, which results in their narrowing and affects the transportation of air from the nose and mouth to the lungs. The rise in asthma occurrences has led to a boost in the discovery of novel asthma medication to treat these conditions. For instance, as reported by Asthma + Lung UK, a UK-based charity assisting people with lung ailments, there were 1,146 asthma-related deaths in England in 2021, which rose to 1,236 in 2022 according to their April 2024 report. This shows a concerning increase in deaths linked to this disease over the year.

Get Your Asthma Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

What is the projected compound annual growth rate (CAGR) of the asthma drugs market from 2025 to 2034, and what factors influence it?
The market size for asthma medications has significantly expanded in the past few years. It is anticipated to rise from $23.96 billion in 2024 to $25.17 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%. The growth during the historic period can be linked to environmental influences, a rise in respiratory illnesses, changes in lifestyles, and enhancements in healthcare infrastructure.

The market size of asthma medications is projected to witness robust expansion in the coming years. It is anticipated to surge to $31.98 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. The upswing during the forecast period can be credited to the escalating levels of air pollution, aging populace growth, amplified healthcare consciousness, personalized medicine developments, and biopharmaceutical breakthroughs. Key trends for the forecast period comprise small molecule treatments, asthma treatment at home, biomarker-driven therapies, advancements in treating severe asthma, and cooperative efforts in asthma research.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

How are the latest trends influencing the growth of the asthma drugs market?
Major firms in the asthma drugs market are focusing on pioneering innovations like fixed-dose combination (FDC) drugs to improve the efficiency of the treatment and ensure the patient's consistency in following the regimen. A fixed-dose combination (FDC) drug is a kind of medication that combines two or more active substances into a single dosage form like a tablet, capsule, or inhaler. For instance, in June 2022, Indamet, a fixed-dose combination (FDC) drug meant for patients with uncontrolled asthma, was introduced in India by Glenmark Pharmaceuticals, an Indian pharmaceutical firm. This novel treatment merges Indacaterol, a long-lasting beta-agonist, with Mometasone Furoate, an inhalable corticosteroid. It is available in various strengths, with Indacaterol being offered at 150 mcg combined with Mometasone at 80 mcg, 160 mcg, and 320 mcg. Indamet is designed for once-daily usage and targets adolescents and adults over the age of 12 years.

What are the major segments of the asthma drugs market and their role in driving growth?
The asthma drugs market covered in this report is segmented -

1) By Type Of Asthma: Allergic, Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma
3) By Therapy: Preventive, Curative
4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs
5) By End-User: Asthma Patients, COPD Patients

Subsegments:
1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies
2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11924

Which regions are key players in the growth of the asthma drugs market?
North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the asthma drugs market?
Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

What Is Covered In The Asthma Drugs Global Market Report?

• Market Size Forecast: Examine the asthma drugs market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the asthma drugs market for a structured understanding.
• Key Players Overview: Analyze major players in the asthma drugs market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the asthma drugs market.
• Segment Contributions: Evaluate how different segments drive overall growth in the asthma drugs market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the asthma drugs market.
• Industry Challenges: Identify potential risks and obstacles affecting the asthma drugs market.
• Competitive Landscape: Review strategic developments in the asthma drugs market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.